Navigation Links
Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
Date:5/12/2008

CHENGDU, China, May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that the Company will present at the Brean Murray All-Cap All-China Conference on Tuesday, May 20, 2008 at 10:15 a.m. EDT. The Conference will be held at the Waldorf Astoria, which is located in New York City.

The presentation will take place in the Sutton Suite and management will participate in meetings with analysts and investors throughout the day. Mr. Stewart Lor, a member of the Board of Directors, will present on the Company's behalf.

Management will discuss the Company's current product portfolio, development pipeline, research and development platform, recent financial highlights and its long-term growth strategy.

Participation is by invitation and registration is mandatory. For more information on the conference contact your Brean Murray representative or visit http://www.breanmurraycarret.com

About Brean Murray

Brean Murray, Carret & Co. was founded over 30 years ago and is a full-service, boutique investment bank dedicated to small cap and emerging growth companies and those who invest in them. As a research-driven securities firm, the firm is dedicated to delivering high quality investment banking services and investment ideas to its clients. The firms focuses on the following sectors: China Small Cap, Consumer Products and Retailing, Healthcare and Biotechnology, Resources and Technology.

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 34 modernized TCMs in the market, 22 of which are listed in
'/>"/>

SOURCE Tianyin Pharmaceutical, Co., Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced the approval of all of its,"f... the District of Delaware,(the "Bankruptcy Court")...relief under Chapter 11 of the United States Bankr...he orders issued by the Bankruptcy Court allow the...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai B... Administration (SFDA) has approved the,investigat...lin project,(Nodlin), an innovative insulin formul...Biolaxy to initiate its first phase I clinical stu...ic of high blood glucose and poor,metabolism. The ...
(Date:11/24/2009)...imary efficacy endpoint has been met for patients ...ancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fir...SX: AEZ) (the "Company"), a global biopharmaceutic...gy, today announced positive efficacy data from a ...conjugate, AEZS-108 (formerly AN-152), in patients...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...why Deb Rislow believes she has risen to her curre...ems for Gundersen Lutheran - at the perfect time...r been a hotter topic as the federal government tr...nd clinics apply it to reduce medical errors, cont... around long enough to have learned plenty of less...
... against potential infringers by licensing the pat...ing activity. Thanks to a recent Federal Circuit C...ce. , ,Typically, the patent owner would do this b...t a party agree to pay for a license and then nego...posals carried little risk of triggering unwanted ...
...h if the robotics engineering team from Benilde-St... had won a national championship against other hig...their competitors were seasoned college students. ...he Minneapolis-area school competed against gradua...boCup. Using robots to navigate a simulated disast...
Other Biology Technology:CIO Leadership Series: Deb Rislow, Gundersen Lutheran 2CIO Leadership Series: Deb Rislow, Gundersen Lutheran 3CIO Leadership Series: Deb Rislow, Gundersen Lutheran 4CIO Leadership Series: Deb Rislow, Gundersen Lutheran 5Patent licensing: For enforcing companies, the rules have changed 2Patent licensing: For enforcing companies, the rules have changed 3Silver linings in the cloud: America's dearth of STEM students 2Silver linings in the cloud: America's dearth of STEM students 3Silver linings in the cloud: America's dearth of STEM students 4
(Date:11/26/2009)...ts have at last worked out a way of using recordin...ird populations. This is the first time sound reco...d into accurate estimates of bird species, populat...ritish Ecological Society,s Journal of Applied Ec...ead to a major advance in our ability to monitor w...
(Date:11/26/2009)...elberg, 27 November 2009 What are the bare essent...ed to produce a cell that can survive on its own? ...nd understand how an entire organism functions as ...t scientists in a partnership between the European..., Germany, and the Centre de Regulacio Genmica (CR...
(Date:11/25/2009)... a hormone produced in the stomach, may be used to...Parkinson,s disease, Yale School of Medicine resea...ue of the Journal of Neuroscience . , Parkinson... neurons in an area of the midbrain known as the s... production. Reduced production of dopamine in la...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Sister to Sister to Host BIKE FOR THE HEART EVENT Sunday October 11th 58718 1Sister to Sister to Host BIKE FOR THE HEART EVENT Sunday October 11th 58718 2Oncolytics Biotech 28R 29 Inc Announces Phase 3 Update Conference Call 14322 1Oncolytics Biotech 28R 29 Inc Announces Phase 3 Update Conference Call 14322 2Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 1Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 2Public Tells Health Care Workers 3A Get Your H1N1 Flu Vaccine 21 5179 3
...A investigators reviewed pharmaceutical ads in Ame...hird contained no references for medical claims; w...ial was available, only a minority of company data... the majority of original research cited in the ad... product,s manufacturer. , In one of the largest ...
...eam of Fox Chase Cancer Center scientists led by i...ed the genetic mutation that keeps a mouse strain ... called helper T cells. The report by Kappes and h...re. , Kappes, laboratory first discovered the mic...e,s laboratory animal facility in 1997. Known as "...
... the first time, researchers have,automatically gr...lution images of cells. This technical feat opens ...rgets by helping to show which,proteins cluster to...arnegie Mellon University, outperforms,existing vi...ys,Professor Robert F. Murphy, whose report, "Data...
Other Biology News:UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims 2UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims 3Fox Chase Cancer Center scientists identify immune-system mutation 2New, automated tool successfully classifies and relates proteins in unprecedented way 2
...yacrylamide gel electrophoresis (2D-PAGE) with bio...core technology platform for proteomic analysis. 2... complex samples limited only in the dynamic range...Quantitative image based analysis of separated pro...
LabWorks Analysis Software from UVP
...apor Trap Models RVT100, RVT400, RVT405DDA, RVT410... UVS400A and UVS800DDA., A non-corrosive, odorles...or use for temperatures ranging from -105 to +260 ...ability and does not evaporate. Far superior to dr...
... is a concentrated formulation of a rinsing buffer...n technology, as well as for manual immunostaining...gati M.D., Department of Pathology, University of ...ended for all the rinsing steps performed when doi...
Biology Products: